NOW APPROVED: EMROSI™ (Minocycline Hydrochloride) Extended-Release Capsules, 40mg
Date | Form | Description | XBRL | Pages | |
---|---|---|---|---|---|
05/15/25 | SCHEDULE 13G/A | Statement of Beneficial Ownership by Certain Investors |
![]() |
9 | |
05/15/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
![]() |
![]() ![]() ![]() |
62 |
05/14/25 | 8-K | Current report |
![]() |
![]() ![]() ![]() |
6 |
05/13/25 | SCHEDULE 13G | Statement of Beneficial Ownership by Certain Investors |
![]() |
4 | |
05/05/25 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
1 | |
05/05/25 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
1 | |
05/05/25 | 4 | Statement of changes in beneficial ownership of securities |
![]() |
1 | |
04/29/25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
![]() |
3 | |
04/29/25 | DEF 14A | Definitive proxy statements |
![]() |
![]() ![]() ![]() |
46 |
04/18/25 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
![]() |
![]() ![]() ![]() |
46 |